RAYMOND JAMES & ASSOCIATES quarter change: Foreign Options, Added
In put and call options, at their filed underlying value (depositary receipts and foreign shares traded over the counter), from the quarter ended 2024-06-30 to 2024-09-30, RAYMOND JAMES & ASSOCIATES opened 2 positions, added to 0, reduced 0, sold out of 1 and left 1 unchanged. The largest increase in value was GSK (+$800,000); the largest decrease was NVO (-$2,075,000).
Two Form 13F-HR filings compared (SEC CIK 1084208): 2024-06-30 (filed 2024-07-19) and 2024-09-30 (filed 2024-10-18). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
No position of this class changed this way between the two filings.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Not available yet | |||